Grant: Engage Grants Program
University of Guelph
$25,000.00
Pre-clinical evaluation of the efficacy of combined THC and CBDA to treat nausea in veterinary medicine
EF 2014-15
Résumé
Cannabis has been used to treat nausea and vomiting for thousands of years. Indeed, this symptom was the first to receive approval for medical marijuana prescriptions. The primary psychoactive ingredient in cannabis is tetrahydrocannabidiol (THC) which has anti-nausea and anti-emetic properties. However, recently, research has shown that the non-psychoactive compounds in cannabis cannabidiol (CBD) and cannabidiolic acid (CBDA) also reduce nausea and vomiting. Indeed, CBDA is 1000 times more potent in reducing nausea and vomiting than CBD, but has no psychomotor effects. CBDA is the precursor to CBD that is found in the plant before it is heated. Although some of the over 60 cannabinoid compounds found in the cannabis plant have been tested alone, there has been very little research on the effects of combinations of these compounds on nausea and vomiting. Here we propose to evaluate the potential of various combinations of THC:CBDA doses to more effectively reduce nausea than either agent on its own. The results of these experiments will provide pre-clinical evaluation of potential new therapies for companion animals undergoing chemotherapy treatment.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
470199-2014
Name nom
Parker, Linda
Department département
Psychology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
6308
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience
Research subject fr
Neurologie du comportement
Partie
1
Nb partie
1
Application title
Pre-clinical evaluation of the efficacy of combined THC and CBDA to treat nausea in veterinary medicine
Keyword
NSERC
Application summary
Cannabis has been used to treat nausea and vomiting for thousands of years. Indeed, this symptom was the first to receive approval for medical marijuana prescriptions. The primary psychoactive ingredient in cannabis is tetrahydrocannabidiol (THC) which has anti-nausea and anti-emetic properties. However, recently, research has shown that the non-psychoactive compounds in cannabis cannabidiol (CBD) and cannabidiolic acid (CBDA) also reduce nausea and vomiting. Indeed, CBDA is 1000 times more potent in reducing nausea and vomiting than CBD, but has no psychomotor effects. CBDA is the precursor to CBD that is found in the plant before it is heated. Although some of the over 60 cannabinoid compounds found in the cannabis plant have been tested alone, there has been very little research on the effects of combinations of these compounds on nausea and vomiting. Here we propose to evaluate the potential of various combinations of THC:CBDA doses to more effectively reduce nausea than either agent on its own. The results of these experiments will provide pre-clinical evaluation of potential new therapies for companion animals undergoing chemotherapy treatment.